Revenue
2019
2020
2021
2022
2023
2024
2025
DBV Technologies S.A. (DBVT)
Price—Loading quote
Net income
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $5.6M | $4.2M | $15.7M | $4.8M | $5.7M | $11.3M | $14.7M |
| Research & development | $116.7M | $89.3M | $60.2M | $75.5M | $70.3M | $101.6M | $115.1M |
| Operating expenses | $152.7M | $120.7M | $92.2M | $101.5M | $104.3M | $170.1M | $185.7M |
| Operating income | −$147.1M | −$116.6M | −$76.4M | −$96.6M | −$98.6M | −$158.8M | −$171.0M |
| EBITDAderived | −$144.1M | −$113.9M | −$72.9M | — | — | — | — |
| Net income | −$146.9M | −$113.9M | $72.7M | $96.3M | −$97.8M | −$159.6M | −$172.0M |
| Basic EPSper diluted share | -$1.05 | -$1.17 | -$0.76 | -$1.24 | -$1.78 | -$2.95 | -$4.65 |
| Diluted EPSper diluted share | -$1.05 | -$1.17 | -$0.76 | -$1.24 | -$1.78 | -$2.95 | -$4.65 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 29, 2026Form 4 | Mohideen PharisChief Medical Officer | SellOrdinary Shares | 534 | $4.86 | $2.6K | 145.0K |
| Dec 18, 2025Form 4 | EPIC Bpifrance +4Other | SellOrdinary Shares · indirect | 1.29M | $4.19 | $5.41M | 7.30M |
| Dec 17, 2025Form 4 | EPIC Bpifrance +4Other | SellOrdinary Shares · indirect | 40.0K | $5.28 | $211.2K | 8.60M |
| Dec 17, 2025Form 4 | EPIC Bpifrance +4Other | SellOrdinary Shares · indirect | 2.04M | $4.84 | $9.86M | 8.64M |
| Nov 21, 2025Form 4 | Mohideen PharisChief Medical Officer | SellOrdinary Shares | 1.6K | $2.77 | $4.5K | 101.5K |